Comments on the three papers by the FDA/CDER research team on the regulatory perspective of the missing data problem.
about
Comments on the three papers by the FDA/CDER research team on the regulatory perspective of the missing data problem.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Comments on the three papers b ...... e of the missing data problem.
@ast
Comments on the three papers b ...... e of the missing data problem.
@en
type
label
Comments on the three papers b ...... e of the missing data problem.
@ast
Comments on the three papers b ...... e of the missing data problem.
@en
prefLabel
Comments on the three papers b ...... e of the missing data problem.
@ast
Comments on the three papers b ...... e of the missing data problem.
@en
P2860
P356
P1476
Comments on the three papers b ...... e of the missing data problem.
@en
P2093
Weichung Joe Shih
P2860
P304
P356
10.1002/SIM.6895
P407
P577
2016-07-01T00:00:00Z